Back
Adaptimmune Therapeutics PLC Vs. Verona Pharma PLC Industry Stock Comparison
Sell
23
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.01
Seasonality Move:
-31.44%
Sell
40
VRNA
Verona Pharma PLC
Last Price:
29.41
Seasonality Move:
-2.95%
Sell
23
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.04. The Score for ADAP is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Verona Pharma PLC (VRNA)
is a Sell
Is Verona Pharma PLC a Buy, Sell or Hold?
- The current Verona Pharma PLC [VRNA] share price is $29.23. The Score for VRNA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- VRNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
VRNA Stock Price Chart
What is Verona Pharma PLC's stock price today?
-
The Verona Pharma PLC share price today is $29.23
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRNA is experiencing selling pressure, which indicates risk of future bearish movement.
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 40.8 | Sell |
| Chaikin Money Flow: | -191017 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.06 - 1.22) | Sell |
| Bollinger Bands (100): | (0.99 - 1.23) | Sell |
VRNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.43 | Buy |
| Relative Strength Index (14 RSI): | 62.36 | Buy |
| Chaikin Money Flow: | -304031 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.64 - 29) | Buy |
| Bollinger Bands (100): | (13.65 - 25.49) | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.08 | Sell |
| 20-day SMA: | 1.16 | Sell |
| 50-day SMA: | 1.16 | Sell |
| 200-day SMA: | 1.09 | Sell |
| 8-day EMA: | 1.08 | Sell |
| 20-day EMA: | 1.12 | Sell |
| 50-day EMA: | 1.13 | Sell |
| 200-day EMA: | 1.1 | Sell |
VRNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.26 | Sell |
| 20-day SMA: | 27.92 | Buy |
| 50-day SMA: | 24.93 | Buy |
| 200-day SMA: | 18.22 | Buy |
| 8-day EMA: | 29.09 | Buy |
| 20-day EMA: | 27.9 | Buy |
| 50-day EMA: | 24.9 | Buy |
| 200-day EMA: | 19.57 | Buy |
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Verona Pharma PLC Earnings Growth & VRNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, an increase next quarter of $0.21 per share, a decrease this year of $1.12 per share, and an increase next year of $0.89 per share.
Adaptimmune Therapeutics PLC Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verona Pharma PLC Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||